News - Key Protein Is Linked to Transverse Myelitis and Multiple Sclerosis

[Guest guest]

Key Protein Is Linked to Transverse Myelitis and Multiple Sclerosis

By Vohrs Hopkins Medicine s Hopkins researchers have discovered a single molecule that is a cause of an autoimmune disease in the central nervous system, called transverse myelitis, that is related to multiple sclerosis. In a study published in the October issue of The Journal of Clinical Investigation, psychiatrist Adam Kaplin and neurologist Kerr, both assistant professors at the s Hopkins School of Medicine, showed that the levels of the protein, IL-6, are dramatically elevated in the spinal fluid of transverse myelitis patients. Although the majority of TM patients suffer a single attack, 15 percent to 30 percent of patients go on to develop full-blown MS. TM evolves rapidly and without warning and usually results in permanent impairment, including weakness of the legs and arms, bowel and bladder dysfunction, pain and paralysis. IL-6 is a chemical messenger that cells of the immune system use to communicate with one another. One of the cell types injured by high levels of IL-6 includes oligodendrocytes, which help produce the protective myelin sheath coating around nerve cells. The findings offer one possible mechanism responsible for demyelinating disorders, such as TM and MS, and may aid in the development of effective therapies against these disorders, the researchers say. "This is the first time a single culprit has been identified as causing a CNS autoimmune disease," Kaplin said. The researchers began investigating the protein IL-6 when they became aware that TM patients suffered from memory impairment and depression. IL-6 has been implicated in mood and concentration disorders. "This discovery is a success story that begins with listening carefully to what patients are telling us about their suffering and then collaborating across disciplines to open up new avenues of investigation," Kaplin said. "TM is related to other autoimmune disorders of the nervous system, including Guillain-Barre syndrome, MS and acute disseminated encephalomyelitis. This study may give us a foothold in understanding all of these disorders and how they are linked together. The benefit is, therefore, not only to those who are paralyzed by TM but to those who have disabilities due to a variety of autoimmune disorders. We are actively using these findings to aid in developing future diagnostic, prognostic and therapeutic advancements," said Kerr, director of the s Hopkins Transverse Myelitis Center, the only center devoted to TM in the world. Researchers analyzed 42 inflammatory proteins in the cerebrospinal fluid of both TM and healthy patients. They found that IL-6 was consistently elevated in TM patients' spinal fluid. Further, the level of IL-6 directly correlated with the severity of paralysis. Using cell culture and animal studies, the researchers confirmed that elevated IL-6 levels were directly injurious to the spinal cord. They showed that spinal fluid from TM patients induced death of spinal cord cells when cultured in a dish and that IL-6, when infused in adult rats, induced paralysis. Under the microscope, tissue from IL-6-infused rats showed demyelination and injury of axons, pathology that was nearly identical to that seen in human patients with TM. Kerr and Kaplin also deduced that the reason IL-6 elevations injure only the spinal cord and not other regions of the nervous system is because distinct regions of the nervous system have different responses to IL-6. They concluded that these different types of responses might be a part of why different autoimmune disorders of the nervous system affect distinct regions and cause distinct symptoms. "When we started, we knew nothing about the bad players in this drama in the spinal cord of CNS autoimmune diseases. It was a classic murder mystery, and we set out together to find out 'who done it,'" Kaplin said. "We've answered who could have done it, and how and where." Funding for this study was provided by the National Institutes of Health. Other investigators involved in the research, conducted solely at s Hopkins, were Deepa M. Deshpande, k , Chitra Krishnan, S. Carmen, Irina Shats, Tara ez, Drummond, Sonny Dike, Mickail Pletnikov, Sanjay C. Keswani, H. Moran, A. Pardo and A. Calabresi.

http://www.jhu.edu/~gazette/2005/07nov05/07keypro.html

Cris KerrAdministrator'Case Health - Health Success Stories' websiteURL: www.casehealth.com.au & www.casehealth.comWebsite Email: Online formatAustralia

About Case Health ...

'Case Health - Health Success Stories' is a non-income-earning community website providing a free health information-sharing service based on visitor's anecdotal stories of health success. The online database also contains a selection of successful research results. Any visitor can submit their own non-identifying health success story, or; search the database for other health success stories of WHAT WORKS then discuss this information with their doctor. Free searches by condition, symptom, or treatment. Don't have time to enter a story via the online submission form? Submit via the email contact form. We'll do the rest. We can also notify you of new stories. Case Health is a safe surfing site and does not ... sell anything, generate SPAM, spy, or conduct any other intrusions.

HONcode accredited website.